A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion (Q40771328)

23 September 2017

A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion (English)

1 reference

23 September 2017

Konduri SD

1

1 reference

23 September 2017

Rao CN

2

1 reference

23 September 2017

Chandrasekar N

3

1 reference

23 September 2017

Tasiou A

4

1 reference

23 September 2017

Mohanam S

5

1 reference

23 September 2017

Kin Y

6

1 reference

23 September 2017

Lakka SS

7

1 reference

23 September 2017

Dinh D

8

1 reference

23 September 2017

Olivero WC

9

1 reference

23 September 2017

Gujrati M

10

1 reference

23 September 2017

Foster DC

11

1 reference

23 September 2017

Kisiel W

12

1 reference

23 September 2017

Rao JS

13

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

23 September 2017

1 reference

23 September 2017

20

1 reference

23 September 2017

47

1 reference

23 September 2017

6938-6945

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204847

23 September 2017

0 references

cites work

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

The role of proteolytic enzymes in cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Identification of one- and two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

The plasminogen-plasmin system in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Isolation and characterization of a metalloproteinase secreted by rat glioma cells in serum-free culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Biology and biochemistry of proteinases in tumor invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

The angiogenic effect of tissue factor on tumors and wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Partial characterization of matrix-associated serine protease inhibitors from human skin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Binding and activation of plasminogen at the surface of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Purification and properties of extracellular matrix-degrading metallo-proteinase overproduced by Rous sarcoma virus-transformed rat liver cell line, and its identification as transin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Comparison of Extracellular Matrix-Degrading Activities between 64-kDa and 90-kDa Gelatinases Purified in Inhibitor-Free Forms from Human Schwannoma Cells1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

7 January 2021

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

7 January 2021

Thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

7 January 2021

Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

7 January 2021

Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

7 January 2021

Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

7 January 2021

Tissue factor in cancer angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204847

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204847

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference